Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Foley

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
British Journal of Clinical Pharmacology|January 1, 1979
Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate)R A Vukovich, J E Foley, B Brown, et al.
The New England Journal of Medicine|December 30, 1993
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima IndiansS Lillioja, D M Mott, M Spraul, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitusS E Kahn, B Montgomery, W Howell, et al.
Diabetes|October 1, 1986
Body composition, adipocyte size, free fatty acid concentration, and glucose tolerance in children of diabetic pregnanciesW G Abbott, P Thuillez, B V Howard, et al.
Diabetologia|May 7, 2011
Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trialJ E Foley, M C Bunck, D L Möller-Goede, et al.
Journal of Wildlife Diseases|August 15, 2000
Serologic and molecular evidence of Ehrlichia spp. in coyotes in CaliforniaN Pusterla, C C Chang, B B Chomel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 1999
Human granulocytic ehrlichiosis in Northern California: two case descriptions with genetic analysis of the EhrlichiaeJ E Foley, L Crawford-Miksza, J S Dumler, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2005
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetesA Mari, W M Sallas, Y L He, et al.
Journal of Veterinary Internal Medicine|March 27, 2010
Salmon poisoning disease in dogs: 29 casesJ E Sykes, S L Marks, S Mapes, et al.
Journal of Clinical Microbiology|September 28, 2001
Aortic valve endocarditis in a dog due to Bartonella clarridgeiaeB B Chomel, K A Mac Donald, R W Kasten, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
British Journal of Clinical Pharmacology|January 1, 1979
Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate)R A Vukovich, J E Foley, B Brown, et al.
The New England Journal of Medicine|December 30, 1993
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima IndiansS Lillioja, D M Mott, M Spraul, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitusS E Kahn, B Montgomery, W Howell, et al.
Diabetes|October 1, 1986
Body composition, adipocyte size, free fatty acid concentration, and glucose tolerance in children of diabetic pregnanciesW G Abbott, P Thuillez, B V Howard, et al.
Diabetologia|May 7, 2011
Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trialJ E Foley, M C Bunck, D L Möller-Goede, et al.
Journal of Wildlife Diseases|August 15, 2000
Serologic and molecular evidence of Ehrlichia spp. in coyotes in CaliforniaN Pusterla, C C Chang, B B Chomel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 1999
Human granulocytic ehrlichiosis in Northern California: two case descriptions with genetic analysis of the EhrlichiaeJ E Foley, L Crawford-Miksza, J S Dumler, et al.
The Journal of Clinical Endocrinology and Metabolism|May 12, 2005
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetesA Mari, W M Sallas, Y L He, et al.
Journal of Veterinary Internal Medicine|March 27, 2010
Salmon poisoning disease in dogs: 29 casesJ E Sykes, S L Marks, S Mapes, et al.
Journal of Clinical Microbiology|September 28, 2001
Aortic valve endocarditis in a dog due to Bartonella clarridgeiaeB B Chomel, K A Mac Donald, R W Kasten, et al.
Pageof 15